Advanced Catheter Therapies

Advanced Catheter Therapies, Inc. (ACT) is an early stage research and development medical device company with a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis.

ACT has initially focused its resources on the problem of restenosis and is developing the game-changing Occlusion Perfusion Catheter™ (OPC™). The OPC is a multi‐lumen balloon catheter designed to temporarily occlude a specific region from blood flow to allow the local delivery of therapeutic agents to the peripheral and coronary vasculature.

Also in the development pipeline are devices to improve endovascular debulking procedures (the clearing of blocked blood vessels).

News

Advanced Catheter Therapies Announces Series B Equity Financing
 
CHATTANOOGA, August 20, 2014 – Advanced Catheter Therapies, Inc. (ACT) (www.acatheter.com) announced today that its $3 million Series B preferred equity financing has been oversubscribed and the company is expanding the round to $4.5 million.  ACT is now actively seeking to complete the round with an additional $1.1 million. ACT is a research and development medical device company with a portfolio of innovative catheter technologies addressing vascular disease and targeted endovascular drug delivery.
 
The Series B equity financing was provided by a majority of the company’s Series A investors...